Frazier Healthcare to Buy MatrixCare From ResMed
Private equity firm Frazier Healthcare Partners is acquiring MatrixCare, ResMed's long-term care software unit, in a deal that trims ResMed's portfolio.
ResMed is offloading MatrixCare, its long-term and post-acute care software platform, to private equity firm Frazier Healthcare Partners. The move signals ResMed is sharpening its focus on its core sleep and respiratory device business rather than sprawling into health-IT software.
For ResMed shareholders, this is worth watching. The company picked up MatrixCare back in 2018 for roughly $750 million, so the exit price and any gain or loss on that investment will matter when details drop. Divestitures like this can unlock capital and improve margin profiles — both things the market tends to reward.
Read more Netflix, Disney, YouTube Eye FIFA World Cup U.S. Rights Deal →
Frazier Healthcare Partners, a Seattle-based firm with deep roots in healthcare investing, clearly sees untapped value in MatrixCare's software suite serving skilled nursing facilities, senior living communities, and home health agencies. Long-term care tech is a fragmented, sticky-revenue space, and PE loves that combination.
For traders, the key near-term catalyst is how ResMed guides on the proceeds and what it plans to do with the cash — buybacks, debt paydown, or reinvestment all move the needle differently. Watch the next earnings call for color on capital allocation priorities post-deal.
Continue reading at SeekingAlpha
